Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial
Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page
- Check5 days agoChange Detected- The record history now includes a new Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates an update to the page's revision history metadata.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Revision: v3.6.5 to the history and removed Revision: v3.6.4, reflecting an administrative update to the record's revision timeline.SummaryDifference0.1%

- Check40 days agoChange DetectedThe study record history now shows a new revision tag v3.6.4, updating the version from v3.6.3. This indicates an administrative update to the record rather than a change to the study data.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.6.3 has been added to the study record history. It indicates an update to the page version and supersedes the previous v3.6.2 entry.SummaryDifference0.1%

- Check69 days agoChange DetectedA frontend revision label was updated from Revision: v3.6.0 to Revision: v3.6.2 in the page history. This reflects a UI/version update behind the study record history rather than changes to the study information.SummaryDifference0.1%

- Check83 days agoChange DetectedRecruitment status updated to no longer looking for participants, and the revision history now shows a new version (v3.6.0) replacing the previous v3.5.5.SummaryDifference0.3%

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.